Holen Sie sich die Stockscreener-App
33.76
6.26%
1.99
Handel nachbörslich:
33.40
-0.36
-1.07%
Guardant Health Inc Aktie (GH) Neueste Nachrichten
Piper Sandler maintains Overweight on Guardant Health stock By Investing.com - Investing.com UK
GHGuardant Health, Inc. Latest Stock News & Market Updates - StockTitan
Guardant Health to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
Guardant Health, Inc. (NASDAQ:GH) Sees Large Decline in Short Interest - MarketBeat
Why Guardant Health, Inc. (NASDAQ:GH) Could Be Worth Watching - Simply Wall St
Natera: Poised For A Great Future But I'd Wait For A Pullback (NASDAQ:NTRA) - Seeking Alpha
Sheffield United takeover completed by COH Sports - Reuters
FDA approves blood-based test screens for colon cancer - MSN
Geode Capital Management LLC Purchases 29,686 Shares of Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Guardant Health director Tariq Musa sells $4,042 in common stock - Investing.com India
Guardant Health Partners with MiBA to Transform Cancer Care with AI-Powered Precision Oncology - StockTitan
Guardant Health, Inc. (NASDAQ:GH) Shares Sold by Franklin Resources Inc. - MarketBeat
Guardant Health director Tariq Musa sells $4,042 in common stock By Investing.com - Investing.com South Africa
Meaningful Insights Biotech Analytics and Guardant Health Announce Strategic Partnership to Optimize Use of Biomarker Testing and Data Analytics to Improve Cancer Care - Marketscreener.com
Guardant Health and COTA partner in advanced oncology R&D - TipRanks
Guardant Health Partners with COTA to Revolutionize Cancer Drug Development Through AI-Powered Data - StockTitan
Y Intercept Hong Kong Ltd Sells 38,937 Shares of Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Guardant Health teams up with Boehringer for cancer test By Investing.com - Investing.com Australia
Guardant Health teams up with Boehringer for cancer test - Investing.com
Guardant Health Announces Collaboration With Boehringer Ingelheim to Develop Companion Diagnostic for Detection of Specific Mutations in Advanced Lung Cancer - Business Wire
Guardant Health Partners with Boehringer Ingelheim on Breakthrough Lung Cancer Diagnostic Test - StockTitan
Insider Selling: Guardant Health, Inc. (NASDAQ:GH) Director Sells 2,320 Shares of Stock - MarketBeat
Guardant Health director Tariq Musa sells $81,200 in stock - Investing.com
681,074 Shares in Guardant Health, Inc. (NASDAQ:GH) Bought by Lord Abbett & CO. LLC - MarketBeat
XTX Topco Ltd Has $409,000 Stock Holdings in Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Guardant Health, Inc. (NASDAQ:GH) Receives $40.60 Consensus Target Price from Analysts - MarketBeat
(GH) Trading Report - Stock Traders Daily
Federal Court Jury Issues Unanimous Verdict that Natera Engaged in False Advertising and Unfair Competition in Deliberate Attempt to Damage Guardant Health's Colorectal Cancer Test, Guardant Reveal - The Eastern Progress Online
Verition Fund Management LLC Buys 25,900 Shares of Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Guardant Health to Share New Research Demonstrating Value of Liquid Biopsy Tests, Real-world Data and AI Analytics in Tailoring Treatment Approaches for Breast Cancer at 2024 San Antonio Breast Cancer Symposium - The Bakersfield Californian
Wellington Management Group LLP Purchases 6,618,785 Shares of Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Guardant Health to Showcase Breakthrough Liquid Biopsy Research at Major Breast Cancer Symposium - StockTitan
Pier Capital LLC Buys 42,575 Shares of Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Guardant Health, Inc. (NASDAQ:GH) Shares Bought by Two Sigma Advisers LP - MarketBeat
Guardant Health, Inc. (NASDAQ:GH) Shares Sold by Polar Asset Management Partners Inc. - MarketBeat
Temasek Holdings Private Ltd Reduces Holdings in Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Charles Schwab Investment Management Inc. Has $23.01 Million Stock Holdings in Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Investors in Guardant Health (NASDAQ:GH) from three years ago are still down 61%, even after 8.6% gain this past week - Yahoo Finance
Strong week for Guardant Health (NASDAQ:GH) shareholders doesn't alleviate pain of three-year loss - Simply Wall St
Guardant Health stock soars to 52-week high of $37.04 By Investing.com - Investing.com Nigeria
Guardant Health Inc (GH) Shares Up 4.11% on Dec 4 - GuruFocus.com
Guardant Health stock soars to 52-week high of $37.04 - Investing.com
Guardant Health Stock Flashing Surefire ‘Buy’ Signal - Forbes
The Manufacturers Life Insurance Company Sells 28,746 Shares of Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Guardant Health (FRA:5GH) Shares Outstanding (EOP) : 123.2 Mil (As of Sep. 2024) - GuruFocus.com
Liquid Biopsy Market Is Booming So Rapidly with Major Giants - openPR
Guardant awarded nearly $293M in false ad trial against Natera - MedTech Dive
Erste Asset Management GmbH Buys New Stake in Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Fred Alger Management LLC Sells 43,039 Shares of Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
GH (Guardant Health) EBITDA per Share : $-3.86 (TTM As of Sep. 2024) - GuruFocus.com
Guardant Health (STU:5GH) EPS (Diluted) : €-3.89 (TTM As of Sep. 2024) - GuruFocus.com
Guardant Health Q3 2024 Earnings Preview - MSN
Guardant Health, Inc. (NASDAQ:GH) Shares Bought by Eventide Asset Management LLC - MarketBeat
Guardant Health (FRA:5GH) EV-to-Revenue : 7.08 (As of Nov. 30, 2024) - GuruFocus.com
Intech Investment Management LLC Invests $754,000 in Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Cerity Partners LLC Buys 68,883 Shares of Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Guardant Health Eyes Earlier Breakeven As Liquid Biopsy Boosts Outlook - Citeline News & Insights
KAS Team Wins $292.5 Million In Jury Trial of Guardant Health v. Natera - Morningstar
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):